Punch & Associates Investment Management Inc. Acquires 10,936 Shares of Addus HomeCare Corporation $ADUS

Punch & Associates Investment Management Inc. lifted its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 6.0% in the first quarter, HoldingsChannel reports. The institutional investor owned 193,890 shares of the company’s stock after buying an additional 10,936 shares during the period. Punch & Associates Investment Management Inc.’s holdings in Addus HomeCare were worth $18,158,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ADUS. Capital Research Global Investors grew its holdings in shares of Addus HomeCare by 22.3% in the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after acquiring an additional 268,192 shares in the last quarter. Freestone Grove Partners LP raised its holdings in Addus HomeCare by 5,035.2% during the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock worth $14,813,000 after acquiring an additional 135,246 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Addus HomeCare by 11.8% during the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock worth $69,689,000 after acquiring an additional 78,415 shares in the last quarter. Empowered Funds LLC boosted its position in Addus HomeCare by 186.1% during the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock valued at $7,617,000 after purchasing an additional 46,137 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. acquired a new position in Addus HomeCare during the second quarter valued at approximately $4,838,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $114.55 on Friday. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $124.43. The company has a market capitalization of $2.14 billion, a price-to-earnings ratio of 21.17, a PEG ratio of 1.53 and a beta of 0.88. The company has a 50-day simple moving average of $99.25 and a 200 day simple moving average of $101.26. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.52 by $0.10. The firm had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business’s revenue was up 7.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.42 EPS. On average, sell-side analysts predict that Addus HomeCare Corporation will post 6.24 earnings per share for the current year.

Insider Activity

In other news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. This represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 788 shares of company stock worth $73,506 in the last three months. Insiders own 4.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ADUS. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a report on Friday. Barclays raised their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. Finally, Citizens Jmp restated a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and an average price target of $131.50.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.